Mark H. Stefaniak
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark H. Stefaniak.
Green Chemistry | 2008
Kim Alfonsi; Juan Colberg; Peter J. Dunn; Thomas Lee Fevig; Sandra M. Jennings; Timothy Allen Johnson; H. Peter Kleine; Craig Knight; Mark A. Nagy; David Austen Perry; Mark H. Stefaniak
Influencing and improving the environmental performance of a large multi-national pharmaceutical company can be achieved with the help of electronic education tools, backed up by site champions and strong site teams. This paper describes the development of two of those education tools.
Tetrahedron Letters | 1980
John Edward Glyn Kemp; Michael D. Closier; Subramanian Narayanaswami; Mark H. Stefaniak
Abstract Triflate or nonaflate esters of alkyl 6α (or β) hydroxypenicillanates are substituted (with inversion) by the soft nucleophiles iodide, bromide, chloride, azide, arylselenoxide, 1 thiocyanate, thiols, and thiolacids; carbon nucleophiles fail. Methoxide (hard) attacks the lactam bond, opening both rings to give a known 11 1,4 thiazine. Iodide substitutes 7α-trifloxycephalosporins, giving 7β-iodocephalosporins.
Bioorganic & Medicinal Chemistry Letters | 1999
John A. Lowe; Weimin Qian; Robert A. Volkmann; Steven D. Heck; Jolanta Nowakowski; Robert B. Nelson; Charles E. Nolan; Dane Liston; Karen M. Ward; Stevin H. Zorn; Celeste Johnson; Michelle Vanase; W. Stephen Faraci; Kimberly A. Verdries; James Baxter; Shawn D. Doran; Martin Sanders; Mike Ashton; Peter John Whittle; Mark H. Stefaniak
The synthesis and SAR of a series of 6-(4-(substituted)phenyl)-2-aminopyridines as inhibitors of nitric oxide synthase are described. Compound 3a from this series shows potent and selective inhibition of the human nNOS isoform, with pharmacokinetics sufficient to provide in vivo inhibition of nNOS activity.
Heterocycles | 2006
M. Jonathan Fray; Paul Allen; Paul R. Bradley; Clare E. Challenger; Michael D. Closier; Tim J. Evans; Mark L. Lewis; John Paul Mathias; Carly L. Nichols; Yvonne M. Po-Ba; Hayley Snow; Mark H. Stefaniak; Hannah V. Vuong
Two routes to prepare a series of six 5-heterocyclic substituted 2-chloro-7-methoxyquinazolin-4-ones are described, where the heterocycle is a substituted or unsubstituted 1-pyrazolyl, 5-pyrazolyl or 2-thiazolyl group. Both routes proceeded via key 2-aminobenzonitrile intermediates.
Tetrahedron Letters | 1979
John Edward Glyn Kemp; Michael D. Closier; Mark H. Stefaniak
Abstract Penicillin N -cyanosulphoximines are obtained by permanganate oxidation of the sulphilimines. Phthalimidosulphoximines are obtained from penicillin or cephalosporin sulphoxides are phthalimidonitrene (from N -aminophthalimide with lead tetraacetate).
Journal of Medicinal Chemistry | 2011
David Simon Millan; Mark Edward Bunnage; Jane L. Burrows; Kenneth John Butcher; Peter G. Dodd; Tim J. Evans; David Fairman; Samantha J. Hughes; Iain Kilty; Arnaud Lemaitre; Russell Andrew Lewthwaite; Axel Mahnke; John Paul Mathias; James Philip; Robert T. Smith; Mark H. Stefaniak; Michael Yeadon; Christopher Phillips
Journal of Medicinal Chemistry | 1989
Colin T. Alabaster; Andrew Simon Bell; Simon F. Campbell; Peter M. Ellis; Christopher G. Henderson; David Stuart Morris; David Anthony Roberts; Keith S. Ruddock; Gillian Mary Ryder Samuels; Mark H. Stefaniak
Journal of Medicinal Chemistry | 1988
Colin T. Alabaster; Andrew Simon Bell; Simon F. Campbell; Peter M. Ellis; Christopher G. Henderson; David Anthony Roberts; Keith S. Ruddock; Gillian Mary Ryder Samuels; Mark H. Stefaniak
Archive | 2003
Julian Blagg; Michael Jonathan Fray; Mark L. Lewis; John Paul Mathias; Mark H. Stefaniak; Alan Stobie
Journal of Medicinal Chemistry | 1995
Michael Jonathan Pfizer C. Fray; David John Bull; K. Cooper; M. J. Parry; Mark H. Stefaniak